APOA1 and Alzheimer disease: Aβ-binding proteins circulating in the plasma were isolated and identified by LC MS. Many apolipoproteins were identified, i.e., apoA-I, apoB-100, apoC-III, and apoE. ApoA-I was reduced in AD and was proposed as an AD biomarker. ApoC-III was reduced in both ND-FH and AD and was proposed as a predictive marker for AD